Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115745836A reveals a blue-light mediated method for C-C bond cleavage, offering cost-effective routes for high-purity pharmaceutical intermediates and functional materials.
Novel catalyst-free synthesis of dithiophosphonates offers green chemistry benefits and supply chain reliability for pharmaceutical intermediate manufacturing partners globally.
Advanced patent CN107033210A details a high-yield Fulvestrant route. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Patent CN1671669A details a high-purity celecoxib synthesis method reducing regioisomers via controlled water and acid catalysis for cost-effective manufacturing.
Patent CN108101830B details a metal-free oxidation route for oxindoles, offering cost reduction in API manufacturing and high-purity intermediates.
Patent CN107573276A reveals NHC-catalyzed indolinone synthesis. High yield, mild conditions offer cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel mild preparation of antineoplastic drug tegafur using 2-benzoyloxy tetrahydrofuran. High yield, >99.7% purity, scalable industrial process.
Patent CN117924403B details a low-toxicity synthesis route for sodium carbenoxolone using toluene and DMAP, ensuring high purity and cost efficiency for pharmaceutical supply chains.
Novel synthetic method for Parecoxib Sodium Impurity I ensures high purity and yield. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel one-pot reduction method for 4-bromoindole offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110668958A reveals a high-purity synthesis route for (R)-3-aminobutanol, a key Dolutegravir intermediate, offering significant cost and supply chain advantages.
Patent CN119118862B reveals one-step agomelatine synthesis reducing complexity. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN117886789A reveals efficient Ir-catalyzed synthesis. Offers high purity pharmaceutical intermediates with scalable cost reduction and supply chain reliability for global buyers.
Patent CN111269075A details a cost-effective nickel-catalyzed route for 2,3-dihydroindanones, offering high regioselectivity and supply chain advantages for pharmaceutical manufacturing.
Novel reductive amination route for influenza inhibitor intermediate. High yield, safe scale-up, and cost-effective pharmaceutical manufacturing solutions.
Patent CN101863830A reveals a high-yield synthesis of 2-amino-5-bromoisonicotinic acid (>60%), offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN1328230C details asymmetric transfer hydrogenation of imines using Rh/Ru/Ir catalysts for high-purity pharmaceutical intermediates.
Patent CN109134392A reveals a mild synthetic route for N2-alkenyl benzotriazoles. Achieve high selectivity and cost reduction in fine chemical manufacturing with scalable processes.
Patent CN113929587A reveals high-yield synthesis route. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel sulfonation resolution method for dexmedetomidine intermediate ensures high yield and purity for pharmaceutical supply chains.